Research study Program year 2020 Source: CMS Open Payments

M16-291

ClinicalTrials.gov NCT03543358

Research payments

$66,660

11 payments

Through program year 2020, $66,660 in research payments was reported against M16-291, across 11 payments, paid by AbbVie, Inc..

Paid by: AbbVie, Inc.
ClinicalTrials.gov: NCT03543358

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$37,327	5
2019	Research	$29,333	6

Breakdown

Who paid Research payments · program years 2019–2020

AbbVie, Inc. $66,660 11 payments

Who received the money Research payments · program years 2019–2020

Ut Md Anderson Cancer Center Teaching hospital · TX $27,500 1 payment
Rutgers The State University Organisation paid for research $13,650 1 payment
City Of Hope National Medical Ctr Teaching hospital · CA $12,363 2 payments
Upmc Hillman Cancer Center Organisation paid for research $10,233 3 payments
Arizona Oncology Organisation paid for research $1,500 1 payment
Arizona Oncology Associates Pc Organisation paid for research $1,414 3 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

5 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.